Home > Insider Trading > Syros Pharmaceuticals Inc.

Syros Pharmaceuticals Inc. (SYRS)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q4 2023 Earnings Call Transcript

Operator: Good morning and welcome to Syros Pharmaceuticals Fourth Quarter and Full Year 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

March 28th, 2024 - News Transcripts

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q3 2023 Earnings Call Transcript

Operator: Good morning and welcome to Syros Pharmaceuticals Third Quarter 2023 Financial Results Conference Call.

Keep Reading →

November 15th, 2023 - News Transcripts

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q2 2023 Earnings Call Transcript

Operator: Good morning, and welcome to Syros Pharmaceuticals' Second Quarter 2023 Financial Results Conference Call. At this time, all participants are in listen only mode.

Keep Reading →

August 10th, 2023 - News Transcripts

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q1 2023 Earnings Call Transcript

Operator: Good morning, and welcome to Syros Pharmaceuticals' First Quarter 2023 Financial Results Conference Call. [Operator Instructions].

Keep Reading →

May 13th, 2023 - News Transcripts

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q4 2022 Earnings Call Transcript

Operator: Good morning, and welcome to Syros Pharmaceuticals Fourth Quarter and Full Year 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

March 6th, 2023 - News Transcripts

5 Best One Dollar Stocks To Buy Now

In this article, we discuss the 5 best one dollar stocks to buy today.

Keep Reading →

August 12th, 2022 - Hedge Funds News

Cathie Wood is Dumping These 15 Stocks

The portfolio value of ARK Investment Management, the New York-based hedge fund managed by Cathie Wood, has increased from over $50 billion at the end of the first quarter of 2021 to more than $53 billion...

Keep Reading →

October 1st, 2021 - Hedge Funds News

Were Hedge Funds Right About Syros Pharmaceuticals, Inc. (SYRS)?

Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities...

Keep Reading →

July 26th, 2021 - Hedge Funds News

Is SYRS A Good Stock To Buy Now?

How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.

Keep Reading →

December 13th, 2020 - Hedge Funds News

Hedge Funds Are Selling Syros Pharmaceuticals, Inc. (SYRS)

The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC.

Keep Reading →

July 5th, 2020 - Hedge Funds News